rs139345520
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002617.4(PEX10):c.685G>C(p.Val229Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,610,988 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V229V) has been classified as Likely benign.
Frequency
Consequence
NM_002617.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PEX10 | NM_002617.4 | c.685G>C | p.Val229Leu | missense_variant | 4/6 | ENST00000447513.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PEX10 | ENST00000447513.7 | c.685G>C | p.Val229Leu | missense_variant | 4/6 | 1 | NM_002617.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.00619 AC: 943AN: 152220Hom.: 5 Cov.: 34
GnomAD3 exomes AF: 0.00155 AC: 377AN: 242962Hom.: 2 AF XY: 0.00113 AC XY: 149AN XY: 132242
GnomAD4 exome AF: 0.000608 AC: 887AN: 1458650Hom.: 10 Cov.: 35 AF XY: 0.000521 AC XY: 378AN XY: 725432
GnomAD4 genome ? AF: 0.00620 AC: 944AN: 152338Hom.: 5 Cov.: 34 AF XY: 0.00623 AC XY: 464AN XY: 74480
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 6A (Zellweger) Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Zellweger spectrum disorders Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 18, 2019 | - - |
Peroxisome biogenesis disorder, complementation group 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 05, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at